Arm: UK chip designer shares surge in market return

United Kingdom News News

Arm: UK chip designer shares surge in market return
United Kingdom Latest News,United Kingdom Headlines
  • 📰 BBCTech
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 55%

The jump in share price was a sign of confidence in Arm, a star of the British tech industry.

Investors snapped up shares of UK chip designer Arm Holdings as it returned to the stock market, sending its market value to more than $60bn .

The sale was the biggest initial public offering of the year, raising $4.87bn for owner Softbank Group."Despite some concerns about the company's exposure to numerous risks in China, it's not stopped a juggernaut of enthusiasm," said Susannah Streeter head of money and markets at Hargreaves Lansdown.

Chief executive Rene Haas said the company saw further opportunity for growth, as investments in artificial intelligence drive demand for its products.Arm's return to the stock market was much anticipated. The firm, which has its headquarters in Cambridge, had faced heavy lobbying to list its shares in the UK.

Mr Haas, who is based in the US, said the firm chose to list on the Nasdaq for its experience handling large share sales by tech firms. He told the BBC that the firm was open to considering listing in London "down the road".

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BBCTech /  🏆 81. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Experts share riskiest driving manoeuvre on British roadsExperts share riskiest driving manoeuvre on British roadsCar drivers had more recorded collisions during 2012 and 2021
Read more »

Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastomaResearch team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastomaAn innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma, has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.
Read more »



Render Time: 2025-02-12 07:14:21